NCT00063934 2019-03-05Oblimersen Plus Doxorubicin and Docetaxel in Treating Patients With Metastatic or Locally Advanced Breast CancerNational Cancer Institute (NCI)Phase 1/2 Terminated31 enrolled 8 charts